Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

BACKGROUND: Stimulation of vascular endothelial growth factor (VEGF) has been observed following transarterial chemoembolization (TACE) in hepatocellular cancer (HCC) and may contribute to tumor regrowth. This pilot study examined whether intravenous (IV) bevacizumab, a monoclonal antibody against V...

Descripción completa

Detalles Bibliográficos
Autores principales: Britten, Carolyn D, Gomes, Antoinette S, Wainberg, Zev A, Elashoff, David, Amado, Rafael, Xin, Yan, Busuttil, Ronald W, Slamon, Dennis J, Finn, Richard S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292503/
https://www.ncbi.nlm.nih.gov/pubmed/22244160
http://dx.doi.org/10.1186/1471-2407-12-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292503/
https://www.ncbi.nlm.nih.gov/pubmed/22244160
http://dx.doi.org/10.1186/1471-2407-12-16

Ejemplares similares